Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...
Project Leader: A. Brent Carter, M.D. Idiopathic pulmonary fibrosis (IPF) is increasing in prevalence, and the recently approved anti-fibrotic therapies have limited efficacy. Alveolar macrophages ...
Core Director: Rui-Ming Liu, Ph.D. Idiopathic pulmonary fibrosis (IPF) is a most enigmatic fatal lung disorder. Although significant progress has been made in our understanding of IPF pathogenesis, ...
"We are honored to partner with MFCR, a highly regarded research organization, on this groundbreaking project," said Alan Herman, ICRF Executive Director. "By supporting Prof. Yarden's innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback